Nanalysis Scientific Corp. (NSCIF)

-30.44% (1Y)

Market Cap	25.76M
Revenue (ttm)	31.62M
Net Income (ttm)	-9.46M
Shares Out	n/a
EPS (ttm)	-0.09
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	20,000
Average Volume	7,071
Open	0.2430
Previous Close	0.2430
Day's Range	0.2265 - 0.2430
52-Week Range	0.1800 - 0.3581
Beta	0.41
RSI	58.08
Earnings Date	Apr 30, 2025

About Nanalysis Scientific

Nanalysis Scientific Corp. develops, manufactures, and sells magnetic resonance technology products in Canada, the United States, Canada, Europe, Asia, and internationally. The company operates through Scientific Equipment and Security Services segment. It offers nuclear magnetic resonance (NMR) spectrometers; magnetic resonance test, and measurement and diagnostic system; 60 MHz and 100 MHz NMR platform; and Cameleon 4 console, a compact alternative to facilitate MRI for teaching. The company also provides and software products, such as NMRGui...

• Industry: Scientific & Technical Instruments
• Sector: Technology
• CEO: Sean Krakiwsky
• Employees: 249
• Stock Exchange: OTCMKTS
• Ticker Symbol: NSCIF

Financial Performance

In 2024, Nanalysis Scientific's revenue was 45.50 million, an increase of 59.82% compared to the previous year's 28.47 million. Losses were -13.61 million, -15.95% less than in 2023.

Financial numbers in CAD